Top Markets
Coin of the day
Lobe Sciences Ltd. Lobe Sciences Ltd.

Lobe Sciences Ltd.

LOBE
Rangering i aksjer #30768
Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the... Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the exploration and advancement of psychedelic pharmaceutical compounds. The company is actively engaged in formulating psilocybin-derived therapeutics, combined with N-acetylcysteine, intended for the treatment of mild traumatic brain injuries and post-traumatic stress disorder. Beyond drug development, it also engineers specialized devices designed to facilitate the efficient delivery of various medications. The organization was previously known as Greenstar Biosciences Corp. before formally changing its name to Lobe Sciences Ltd. in November 2020. Its main corporate office is situated in Vancouver, Canada.
Aksjekurs
$0.05504527
Sist synkronisert: 2026-08-17
Markedsverdi
$15.64M
Endring (1 dag)
0.00%
Endring (1 år)
38.75%
Land
CA
Handel Lobe Sciences Ltd. (LOBE)

Kategori

Inntekter for Lobe Sciences Ltd. (LOBE)
Inntekter i 2026 TTM: 0
Ifølge Lobe Sciences Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Lobe Sciences Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter